Enchem (A348370) investor relations material

Executive summary

• Financial statements for the nine months ended September 30, 2025, were reviewed and found to be prepared in accordance with K-IFRS 1034, with no material misstatements identified.

• The company operates globally in electronic materials, primarily electrolytes for secondary batteries, with subsidiaries in Korea, the US, China, Poland, Hungary, Indonesia, France, and Canada.

Financial highlights

• Consolidated revenue for the nine months ended September 30, 2025, was ₩239.2 billion, down from ₩287.9 billion year-over-year.

• Operating loss for the period was ₩49.1 billion, compared to a loss of ₩16.6 billion in the prior year.

• Net loss attributable to owners for the period was ₩31.1 billion, compared to a net loss of ₩364.8 billion in the prior year.

• Basic EPS for the nine months was -₩1,655, compared to -₩19,059 year-over-year.

• Cash and cash equivalents at period end were ₩12.0 billion, down from ₩102.0 billion at the previous year-end.

Outlook and guidance

• Management expects continued ability to generate revenue through product innovation despite global market uncertainties.

• No significant risks identified that would materially impact financial performance or position as of the reporting date.